Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsay Wilde

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and BeyondLindsay Wilde, Jonathan Pan
Blood|January 30, 2025
Targeting CD47: many misses; hopeful for a hitLindsay Wilde, Margaret Kasner
Hematology. American Society of Hematology. Education Program|December 10, 2021
Whom should we treat with novel agents? Specific indications for specific and challenging populationsLindsay Wilde, Margaret Kasner
Current Opinion in Urology|August 13, 2016
Combination immunotherapy in genitourinary malignanciesJean Hoffman-Censits, Lindsay Wilde
American Journal of Hematology|August 28, 2024
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colonMichael Keith Alister Zimmerman, Lindsay Wilde
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|June 5, 2016
Monthly "Grief Rounds" to Improve Residents' Experience and Decrease Burnout in a Medical Intensive Care Unit RotationLindsay Wilde, Brooke Worster, David Oxman
World Journal of Clinical Oncology|September 4, 2020
B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemiaLindsay Wilde, Sabarina Ramanathan, Margaret Kasner
Frontiers in Oncology|November 16, 2020
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic SyndromeJonathan Pan, Daniel Altman, Lindsay Wilde
The Canadian Journal of Urology|December 21, 2017
Recurrent renal cell carcinoma presenting as a solitary left ventricular massLindsay Wilde, Praveen Mehrotra, Jean Hoffman-Censits
Frontiers in Oncology|October 27, 2022
Editorial: COVID-19 and hematological malignancies: Volume IILindsay Wilde, Adam Binder, Claudio Cerchione, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and BeyondLindsay Wilde, Jonathan Pan
Blood|January 30, 2025
Targeting CD47: many misses; hopeful for a hitLindsay Wilde, Margaret Kasner
Hematology. American Society of Hematology. Education Program|December 10, 2021
Whom should we treat with novel agents? Specific indications for specific and challenging populationsLindsay Wilde, Margaret Kasner
Current Opinion in Urology|August 13, 2016
Combination immunotherapy in genitourinary malignanciesJean Hoffman-Censits, Lindsay Wilde
American Journal of Hematology|August 28, 2024
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colonMichael Keith Alister Zimmerman, Lindsay Wilde
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|June 5, 2016
Monthly "Grief Rounds" to Improve Residents' Experience and Decrease Burnout in a Medical Intensive Care Unit RotationLindsay Wilde, Brooke Worster, David Oxman
World Journal of Clinical Oncology|September 4, 2020
B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemiaLindsay Wilde, Sabarina Ramanathan, Margaret Kasner
Frontiers in Oncology|November 16, 2020
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic SyndromeJonathan Pan, Daniel Altman, Lindsay Wilde
The Canadian Journal of Urology|December 21, 2017
Recurrent renal cell carcinoma presenting as a solitary left ventricular massLindsay Wilde, Praveen Mehrotra, Jean Hoffman-Censits
Frontiers in Oncology|October 27, 2022
Editorial: COVID-19 and hematological malignancies: Volume IILindsay Wilde, Adam Binder, Claudio Cerchione, et al.
Pageof 4